Matthew C. Wong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Matthew C. Wong has a total of 99 co-authors. Here are the top co-authors by number of shared publications:
- Jennifer Ann Wargo
The University of Texas MD Anderson Cancer Center
185 shared publications - Nadim J. Ajami
Platform for Innovative Microbiome and Translational Research (PRIME-TR), The University of Texas MD Anderson Cancer Center, Houston, USA
185 shared publications - Ashish Damania
Department of Genomic Medicine, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX 77030-4009, USA
184 shared publications - Christine B. Peterson
Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
162 shared publications - Michael T. Tetzlaff
Departments of Pathology and Dermatology, Dermatopathology and Oral Pathology Unit University of California San Francisco San Francisco California USA
162 shared publications - Brian Weiner
Immuneering Corporation, Cambridge, MA, USA
161 shared publications
Latest Publications
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S1 from Inflammation Mediated by Gut Microbiome Alterations Promotes Lung Cancer Development and an Immunosuppressed Tumor Microenvironment
Supplementary figure S1. Effects of fecal microbiota transfer from Lcn2-deficient mice in various mouse models.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S1 from Inflammation Mediated by Gut Microbiome Alterations Promotes Lung Cancer Development and an Immunosuppressed Tumor Microenvironment
Supplementary figure S1. Effects of fecal microbiota transfer from Lcn2-deficient mice in various mouse models.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Table S5 from Inflammation Mediated by Gut Microbiome Alterations Promotes Lung Cancer Development and an Immunosuppressed Tumor Microenvironment
Differentially expressed genes in the myeloid cluster of the colonic lamina propria.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S5 from Inflammation Mediated by Gut Microbiome Alterations Promotes Lung Cancer Development and an Immunosuppressed Tumor Microenvironment
Differentially expressed genes in the myeloid cluster of the colonic lamina propria.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S5 from Randomized Placebo-Controlled, Biomarker-Stratified Phase Ib Microbiome Modulation in Melanoma: Impact of Antibiotic Preconditioning on Microbiome and Immunity
Correlation between qPCR derived and WGS derived Ruminococcaceae family abundance at baseline
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S5 from Randomized Placebo-Controlled, Biomarker-Stratified Phase Ib Microbiome Modulation in Melanoma: Impact of Antibiotic Preconditioning on Microbiome and Immunity
Correlation between qPCR derived and WGS derived Ruminococcaceae family abundance at baseline
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S12 from Randomized Placebo-Controlled, Biomarker-Stratified Phase Ib Microbiome Modulation in Melanoma: Impact of Antibiotic Preconditioning on Microbiome and Immunity
Longitudinal taxonomic abundance of Ruminococcaceae species
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S12 from Randomized Placebo-Controlled, Biomarker-Stratified Phase Ib Microbiome Modulation in Melanoma: Impact of Antibiotic Preconditioning on Microbiome and Immunity
Longitudinal taxonomic abundance of Ruminococcaceae species
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S16 from Randomized Placebo-Controlled, Biomarker-Stratified Phase Ib Microbiome Modulation in Melanoma: Impact of Antibiotic Preconditioning on Microbiome and Immunity
CD8 intra-tumoral infiltration percentage by IHC
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S16 from Randomized Placebo-Controlled, Biomarker-Stratified Phase Ib Microbiome Modulation in Melanoma: Impact of Antibiotic Preconditioning on Microbiome and Immunity
CD8 intra-tumoral infiltration percentage by IHC
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S13 from Randomized Placebo-Controlled, Biomarker-Stratified Phase Ib Microbiome Modulation in Melanoma: Impact of Antibiotic Preconditioning on Microbiome and Immunity
Assessment of gut microbiome networks by treatment arm and across timepoints
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S13 from Randomized Placebo-Controlled, Biomarker-Stratified Phase Ib Microbiome Modulation in Melanoma: Impact of Antibiotic Preconditioning on Microbiome and Immunity
Assessment of gut microbiome networks by treatment arm and across timepoints
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Table S6 from Inflammation Mediated by Gut Microbiome Alterations Promotes Lung Cancer Development and an Immunosuppressed Tumor Microenvironment
Differentially expressed genes in the tumor microenvironment.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S6 from Inflammation Mediated by Gut Microbiome Alterations Promotes Lung Cancer Development and an Immunosuppressed Tumor Microenvironment
Differentially expressed genes in the tumor microenvironment.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S2 from Inflammation Mediated by Gut Microbiome Alterations Promotes Lung Cancer Development and an Immunosuppressed Tumor Microenvironment
Supplementary figure S2. scRNA-seq of the colonic lamina propria in the syngeneic mice following FMT.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S2 from Inflammation Mediated by Gut Microbiome Alterations Promotes Lung Cancer Development and an Immunosuppressed Tumor Microenvironment
Supplementary figure S2. scRNA-seq of the colonic lamina propria in the syngeneic mice following FMT.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S6 from Randomized Placebo-Controlled, Biomarker-Stratified Phase Ib Microbiome Modulation in Melanoma: Impact of Antibiotic Preconditioning on Microbiome and Immunity
Spore former family relative abundance over time
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S6 from Randomized Placebo-Controlled, Biomarker-Stratified Phase Ib Microbiome Modulation in Melanoma: Impact of Antibiotic Preconditioning on Microbiome and Immunity
Spore former family relative abundance over time
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S7 from Randomized Placebo-Controlled, Biomarker-Stratified Phase Ib Microbiome Modulation in Melanoma: Impact of Antibiotic Preconditioning on Microbiome and Immunity
Supplementary Table S7 from Randomized Placebo-Controlled, Biomarker-Stratified Phase Ib Microbiome Modulation in Melanoma: Impact of Antibiotic Preconditioning on Microbiome and Immunity
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S7 from Randomized Placebo-Controlled, Biomarker-Stratified Phase Ib Microbiome Modulation in Melanoma: Impact of Antibiotic Preconditioning on Microbiome and Immunity
Supplementary Table S7 from Randomized Placebo-Controlled, Biomarker-Stratified Phase Ib Microbiome Modulation in Melanoma: Impact of Antibiotic Preconditioning on Microbiome and Immunity